Drug Interactions between Lupron Depot and Zytiga
This report displays the potential drug interactions for the following 2 drugs:
- Lupron Depot (leuprolide)
- Zytiga (abiraterone)
Interactions between your drugs
No interactions were found between Lupron Depot and Zytiga. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Lupron Depot
A total of 280 drugs are known to interact with Lupron Depot.
- Lupron depot is in the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics.
- Lupron depot is used to treat the following conditions:
Zytiga
A total of 408 drugs are known to interact with Zytiga.
- Zytiga is in the drug class miscellaneous antineoplastics.
- Zytiga is used to treat Prostate Cancer.
Drug and food interactions
abiraterone food
Applies to: Zytiga (abiraterone)
This interaction does not apply to abiraterone acetate (Yonsa) 125 mg tablets, which can be taken with or without food.
Taking abiraterone with food increases the amount of medicine that gets absorbed by the body for certain formulations. This may increase the risk of side effects such as high blood pressure, water retention, and a condition called hypokalemia (low blood potassium), which in severe cases can lead to muscle weakness, paralysis, breathing and swallowing difficulties (due to muscle paralysis), and irregular heart rhythm. You should take abiraterone once a day on an empty stomach. No food should be eaten for at least two hours before and one hour after taking abiraterone. Let your doctor know if you experience nausea, vomiting, constipation, abdominal cramping, confusion, dizziness, lightheadedness, fainting, muscle weakness, muscle cramps, numbness or tingling, rapid heartbeat, chest pain, and/or swelling in the legs or feet, as these may be symptoms of hypokalemia or excessive effects of abiraterone. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.